Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Quorum Health Corp
SIC 8062 · Services-General Medical & Surgical Hospitals, NEC
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Quorum Health Corp
SIC 8062 · Services-General Medical & Surgical Hospitals, NEC
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Quorum Health Corp
SIC 8062 · Services-General Medical & Surgical Hospitals, NEC
Notes
Support
about
terms
Quorum Health Corp
CIK:
0001650445
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]
Net operating revenues
$ 343,787
$ 442,805
Operating costs and expenses:
Salaries and benefits
176,244
225,075
Supplies
42,016
51,385
Other operating expenses
124,894
136,789
Depreciation and amortization
12,218
14,639
Lease costs and rent
9,806
11,531
Electronic health records incentives
26
Legal, professional and settlement costs
11,341
685
Impairment of long-lived assets and goodwill
12,000
8,860
Loss (gain) on sale of hospitals, net
2,421
0
Loss on closure of hospitals, net
202
0
Total operating costs and expenses
391,142
448,990
Income (loss) from operations
(47,355)
(6,185)
Interest expense, net
32,034
32,266
Income (loss) before income taxes
(79,389)
(38,451)
Provision for (benefit from) income taxes
112
155
Net income (loss)
(79,501)
(38,606)
Less: Net income (loss) attributable to noncontrolling interests
271
400
Net income (loss) attributable to Quorum Health Corporation
$ (79,772)
$ (39,006)
Earnings (loss) per share attributable to Quorum Health Corporation stockholders:
Basic and diluted
$ (2.61)
$ (1.33)
Weighted-average shares outstanding:
Basic and diluted
30,512,747
29,438,015
v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:
Net income (loss)
$ (79,501)
$ (38,606)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
12,218
14,639
Non-cash interest expense, net
2,381
1,939
Provision for (benefit from) deferred income taxes
37
90
Stock-based compensation expense
1,063
1,770
Impairment of long-lived assets and goodwill
12,000
8,860
Loss (gain) on sale of hospitals, net
2,421
0
Non-cash portion of loss (gain) on hospital closures
(1,608)
(567)
Changes in reserves for self-insurance claims, net of payments
(595)
4,160
Other non-cash expense (income), net
187
(1,372)
Changes in operating assets and liabilities, net of acquisitions and divestitures:
Patient accounts receivable
16,059
(3,986)
Due from and due to third-party payors, net
(2,216)
(4,421)
Inventories, prepaid expenses and other current assets
512
4,911
Accounts payable and accrued liabilities
29,772
20,146
Long-term assets and liabilities, net
(1,467)
515
Net cash provided by (used in) operating activities
(8,737)
8,078
Cash flows from investing activities:
Capital expenditures for property and equipment
(10,306)
(8,292)
Capital expenditures for software
(1,683)
(1,191)
Acquisitions, net of cash acquired
0
(455)
Proceeds from the sale of hospitals
990
0
Other investing activities, net
334
1,729
Net cash provided by (used in) investing activities
(10,665)
(8,209)
Cash flows from financing activities:
Borrowings under revolving credit facilities
129,000
152,000
Repayments under revolving credit facilities
(80,000)
(150,000)
Borrowings of long-term debt
11
161
Repayments of long-term debt
(515)
(1,833)
Payments on purchase contracts
(701)
0
Cancellation of restricted stock awards for payroll tax withholdings on vested shares
(157)
(461)
Cash distributions to noncontrolling investors
0
(1,223)
Net cash provided by (used in) financing activities
47,638
(1,356)
Net change in cash, cash equivalents and restricted cash
28,236
(1,487)
Cash and cash equivalents at beginning of period
3,145
3,203
Cash and cash equivalents at end of period
31,381
1,716
Supplemental cash flow information:
Interest payments, net
18,243
18,215
Income tax payments, net
0
0
Non-cash purchases of property and equipment under finance lease obligations
$ 128
$ 79
v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Current assets:
Cash and cash equivalents
$ 31,381
$ 3,145
Patient accounts receivable
270,826
286,901
Inventories
38,872
38,747
Prepaid expenses
20,206
19,606
Due from third-party payors
37,736
33,385
Other current assets
24,668
27,259
Total current assets
423,689
409,043
Property and equipment, net
479,084
492,016
Goodwill
391,414
391,724
Intangible assets, net
49,316
49,155
Operating lease right-of-use assets
71,091
74,335
Other long-term assets
72,767
75,612
Total assets
1,487,361
1,491,885
Current liabilities:
Current maturities of long-term debt
1,262,744
1,211,485
Current portion of operating lease liabilities
20,994
22,506
Accounts payable
163,273
156,669
Accrued liabilities:
Accrued salaries and benefits
59,174
51,731
Accrued interest
32,410
21,066
Due to third-party payors
46,143
44,008
Other current liabilities
42,376
43,329
Total current liabilities
1,627,114
1,550,794
Long-term debt
20,569
20,988
Long-term operating lease liabilities
50,714
52,601
Deferred income tax liabilities, net
7,841
7,683
Other long-term liabilities
93,375
93,535
Total liabilities
1,799,613
1,725,601
Redeemable noncontrolling interests
2,286
2,278
$ 2,278
$ 2,278
Quorum Health Corporation stockholders' equity (deficit):
Preferred stock, $0.0001 par value per share, 100,000,000 shares authorized, none issued
0
0
Common stock, $0.0001 par value per share, 300,000,000 shares authorized; 32,664,536 shares issued and outstanding at March 31, 2020 and 32,871,019 shares issued and outstanding at December 31, 2019
3
3
Additional paid-in capital
562,429
561,541
Accumulated other comprehensive income (loss)
418
359
Accumulated deficit
(892,891)
(813,119)
Total Quorum Health Corporation stockholders' equity (deficit)
(330,041)
(251,216)
Nonredeemable noncontrolling interests
15,503
15,222
Total equity (deficit)
(314,538)
(235,994)
$ (114,129)
$ (74,930)
Total liabilities and equity
$ 1,487,361
$ 1,491,885